Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.9230
+0.0130 (1.43%)
At close: Apr 10, 2026
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 23 employees as of September 30, 2025. The number of employees decreased by 6 or -20.69% compared to the same quarter last year.
Employees
23
Change
-6
Growth
-20.69%
Revenue / Employee
n/a
Profits / Employee
-$515,350
Market Cap
10.19M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| HOOKIPA Pharma | 87 |
| NKGen Biotech | 26 |
| Zeo ScientifiX | 20 |
| ZIVO Bioscience | 7 |
| Synlogic | 1 |
Brainstorm Cell Therapeutics News
- 10 days ago - BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 6 weeks ago - Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February - PRNewsWire
- 7 weeks ago - Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market - PRNewsWire
- 5 months ago - BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 5 months ago - Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 8 months ago - BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 8 months ago - BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - PRNewsWire
- 9 months ago - BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB - PRNewsWire